ClinicalTrials.govpublic full text
A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate Cancer
prostate cancer, hormone resistant prostate cancer, endothelin a receptor antagonist, endothelin a, endothelin a antagonist, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 845003
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.